scispace - formally typeset
E

Ennio Tasciotti

Researcher at Houston Methodist Hospital

Publications -  216
Citations -  9469

Ennio Tasciotti is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Tissue engineering. The author has an hindex of 42, co-authored 212 publications receiving 7526 citations. Previous affiliations of Ennio Tasciotti include University of Akron & Open University.

Papers
More filters
Journal ArticleDOI

Localized inhibition of P2X7R at the spinal cord injury site improves neurogenic bladder dysfunction by decreasing urothelial P2X3R expression in rats

TL;DR: Localized inhibition of P2X7R for two weeks can be associated with reduced number of microglia and attenuated bladder hyperexcitability mediated by downregulation of urothelial P2x3R in rats with neurogenic bladder dysfunction and independently of locomotor improvements.
Journal ArticleDOI

In Situ Reductive Synthesis of Structural Supported Gold Nanorods in Porous Silicon Particles for Multifunctional Nanovectors

TL;DR: Porous silicon nanodisks (PSD) may be a promising injectable, multifunctional nanovector for biomedical application and surface-enhanced raman scattering (SERS) using PSD/AuNR as particle substrates was demonstrated.
Journal ArticleDOI

Composite microsphere-functionalized scaffold for the controlled release of small molecules in tissue engineering

TL;DR: The presented strategy establishes the basis of a versatile scaffold for the controlled release of small molecules and for culturing mesenchymal stem cells for regenerative medicine applications.
Journal ArticleDOI

Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow-derived counterparts

TL;DR: The data demonstrate that the isolation protocol identifies and validates mesenchymal stem cells with superior clonal, proliferative, and developmental potential from cortical bone compared to the bone marrow niche although marrow persists as the typical source for mesenchyl stem cells both in the literature and current pre-clinical therapies.
Journal ArticleDOI

Inflammation and Cancer: In Medio Stat Nano

TL;DR: The role of inflammation in the different steps of tumor development and the strategies based on the use of nanoparticles that exploit the inflammatory pathways in order to selectively target the tumor-associated microenvironment for therapeutic and diagnostic purposes are discussed.